Product Information
CLOPIDOGREL 75 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0472 per EA under NDC 68084053601. Its NADAC has been published 625 times since Oct 15, 2014.
FDA first approved this application on May 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
American Health PackagingNDC
68084053601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076274FDA Approved
5/17/2012
TE Code
AB
On Market Since
4/24/2014
Pharmacological Classes
Price Statistics
The NADAC for CLOPIDOGREL 75 MG TABLET has been published 625 times since Oct 15, 2014, and over the history we have for it it has declined 53.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0472 per EA |
|---|---|
| All-time high | $0.1176 (Dec 10, 2014) |
| All-time low | $0.0469 (Jul 22, 2026) |
| 52-week high | $0.0563 |
| 52-week low | $0.0469 |
| Median price | $0.0645 |
| Average price | $0.0672 |
| Largest weekly change | -18.5% (Nov 20, 2024) |
| Weeks tracked | 625 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clopidogrel Bisulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOPIDOGREL 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOPIDOGREL 75 MG TABLET, manufactured by American Health Packaging, is $0.0472 per EA (NDC 68084053601), effective Sep 30, 2026.
How has the price of CLOPIDOGREL 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOPIDOGREL 75 MG TABLET has declined 53.8%. It has been tracked across 625 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for CLOPIDOGREL 75 MG TABLET?
Since Oct 15, 2014, the NADAC for CLOPIDOGREL 75 MG TABLET has ranged from a low of $0.0469 (Jul 22, 2026) to a high of $0.1176 (Dec 10, 2014), with a median of $0.0645 per EA.
Are there cheaper alternatives to CLOPIDOGREL 75 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOPIDOGREL 75 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOPIDOGREL 75 MG TABLET?
CLOPIDOGREL 75 MG TABLET (NDC 68084053601) is labeled by American Health Packaging, and CMS classifies it as a generic product.